Publication | Closed Access

BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS

Hematological MalignancyTumor BiologyConsecutive SeriesHealth SciencesMedicineHematologyMyeloid NeoplasiaPathologyAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyCancer ResearchBcr-abl1 Compound Mutants